surpass cvot tirzepatide 💡 New insight in diabetes care: In patients with T2DM and ASCVD, the SURPASS-CVOT trial found that was noninferior to dulaglutide for major cardiovascular events (12.2% vs 13.1%; HR 0.92). What Reduction of prevalence of patients

Manage fluids earlier in the evening to reduce nocturia

Beneficial Effects On Markers Of Insulin Resistance (6 trials) A number of trials indicated that inositol improves on glucose metabolism and insulin resistance: reduced fasting insulin levels reduced fasting glucose reduced HOMA-IR (a measure of insulin resistance) increased glucose to insulin ratio

Delara Tavakoli is a leading specialist in functional medicine, focusing on addressing the root causes of chronic health issues to promote long-term wellness

Weeks 17-24: Sustained Progress Weight Loss: 17-20% cumulative (42-50 pounds total) Dose: 9mg or 12mg maintenance Primary Focus: Consistency and optimization Weight loss continues at 2-3 pounds per week